Loading stock data...

Trinity League India Limited

BSE: TRINITYLEA

BSE
12.82 -1.42 (-9.97%)

Prev Close

14.24

Open Price

13.65

Volume

2,500

Today Low / High

12.82 / 13.65

52 WK Low / High

9.01 / 14.75

Range

12 - 13

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 12.82, reflecting a change of -1.42 (-9.97191%). The expected target range on the BSE is 12 - 13. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 13.65 -6.08%
24 Feb 12.40 14.84%
23 Feb 13.99 -2.43%
20 Feb 14.30 -10.70%
19 Feb 13.99 -7.08%
18 Feb 13.00 0.00%
17 Feb 13.43 0.00%
16 Feb 13.49 0.00%
13 Feb 13.49 0.00%
10 Feb 13.49 0.00%
09 Feb 11.30 10.00%
06 Feb 12.62 -10.46%
04 Feb 12.50 0.00%
03 Feb 12.04 -0.33%
02 Feb 11.48 4.97%
01 Feb 11.48 0.00%
30 Jan 12.06 0.00%
29 Jan 13.10 -3.28%
28 Jan 13.33 0.00%

Trinity League India Limited Graph

Trinity League India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Trinity League India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 12.82, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 12.82 12.95 11.65 - 14.24
13.08 10.46 - 15.69
13.20 9.24 - 17.17
Bearish Scenario 12.82 12.69 11.42 - 13.96
12.56 10.05 - 15.08
12.44 8.70 - 16.17

Overview of Trinity League India Limited

ISIN

INE884X01011

Industry

Medical - Pharmaceuticals

Vol.Avg

2,021

Market Cap

101,494,658

Last Dividend

0

Official Website

Visit Website

IPO Date

2011-08-12

DCF Diff

15.81

DCF

-5

Financial Ratios Every Investor Needs

Stock Rating Details for TRINITYLEA

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.27 Cr 0.21 Cr 0.05 Cr 0.2026 0.00 Cr 0.00 Cr -0.13 Cr -0.31 Cr -0.39 -0.24 Cr -1.1579
2024-03-31 0.06 Cr 0.15 Cr -0.09 Cr -1.4951 0.00 Cr 0.03 Cr -0.31 Cr -2.70 Cr -3.41 3.16 Cr -43.7298
2023-03-31 3.46 Cr 0.20 Cr 3.26 Cr 0.9429 0.00 Cr 0.79 Cr 3.00 Cr 0.11 Cr 0.19 0.36 Cr 0.0306
2022-03-31 1.79 Cr 0.18 Cr 1.61 Cr 0.8990 0.00 Cr 0.08 Cr 0.38 Cr 0.21 Cr 0.41 0.41 Cr 0.1162
2021-03-31 0.76 Cr 0.20 Cr 0.57 Cr 0.7413 0.00 Cr 0.13 Cr 0.04 Cr -0.49 Cr -0.97 -0.33 Cr -0.6458

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.03 Cr 2.88 Cr 0.04 Cr 2.8430 Cr 0.00 Cr -0.03 Cr 0.00 Cr 0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.0357 Cr
2024-03-31 0.03 Cr 3.24 Cr 0.09 Cr 3.1510 Cr 0.02 Cr -0.03 Cr 0.00 Cr 0.22 Cr 0.00 Cr 0.00 Cr 0.38 Cr 0.0876 Cr
2023-03-31 0.02 Cr 6.00 Cr 0.14 Cr 5.8535 Cr 0.09 Cr 0.07 Cr 0.00 Cr 0.30 Cr 0.00 Cr 0.00 Cr 3.03 Cr 0.1426 Cr
2022-03-31 0.01 Cr 4.11 Cr 1.64 Cr 2.4702 Cr 1.49 Cr 1.47 Cr 0.00 Cr 0.30 Cr 0.00 Cr 0.00 Cr 3.04 Cr 1.6294 Cr
2021-03-31 0.01 Cr 3.11 Cr 0.84 Cr 2.2670 Cr 0.80 Cr 0.79 Cr 0.00 Cr 0.50 Cr 0.00 Cr 0.00 Cr 1.47 Cr 0.7406 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -0.2062 Cr 0.2114 Cr 0.0000 Cr -0.2062 Cr 0.0052 Cr 0.0306 Cr 0.0000 Cr -0.3080 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -0.2318 Cr 0.2506 Cr -0.0149 Cr -0.2318 Cr 0.0039 Cr 0.0254 Cr 0.0000 Cr -2.7071 Cr -0.0149 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 -2.0772 Cr 0.2120 Cr 1.8740 Cr -2.0772 Cr 0.0089 Cr 0.0215 Cr 0.0000 Cr 0.1468 Cr -0.0149 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 0.3498 Cr -0.9677 Cr 0.6164 Cr 0.3498 Cr -0.0015 Cr 0.0126 Cr 0.0000 Cr 0.2079 Cr 0.6164 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 1.4171 Cr -1.5590 Cr -0.0385 Cr 1.1824 Cr -0.1804 Cr 0.0141 Cr -0.2347 Cr 0.1791 Cr -0.0385 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 0.00 Cr 0.05 Cr -0.05 Cr 0.0000 -0.15 Cr -0.10 Cr -0.13 -0.14 Cr 0.0000
2025-06-30 0.00 Cr 0.06 Cr -0.06 Cr 0.0000 -0.12 Cr -0.08 Cr -0.10 -0.11 Cr 0.0000
2025-03-31 0.26 Cr 0.06 Cr 0.20 Cr 0.7644 0.15 Cr 0.21 Cr 0.26 0.23 Cr 0.7912
2024-12-31 0.00 Cr 0.05 Cr -0.05 Cr 0.0000 -0.09 Cr -0.06 Cr -0.08 -0.05 Cr 0.0000
2024-09-30 0.01 Cr 0.05 Cr -0.05 Cr -9.5800 -0.10 Cr -0.05 Cr -0.06 -0.03 Cr -9.3800

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.02 Cr 0.00 Cr 0.02 Cr 2.38 Cr 0.00 Cr 2.50 Cr 0.14 Cr 2.70 Cr 0.04 Cr
2025-06-30 0.00 Cr 0.00 Cr 0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -2.84 Cr
2025-03-31 0.03 Cr 0.00 Cr 0.03 Cr 2.56 Cr 0.00 Cr 2.65 Cr 0.17 Cr 2.88 Cr 0.04 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -2.70 Cr
2024-09-30 0.03 Cr 0.00 Cr 0.03 Cr 2.35 Cr 0.00 Cr 2.49 Cr 0.19 Cr 2.73 Cr 0.03 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.21 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.06 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -0.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹841.40 ₹100,970,844,773.00 ₹78,530.00

Key Executives

Chairman & MD
Devinder Kumar Jain

Gender: male

Year Born: 1954

Company Secretary & Compliance Officer
Gaurav Bajpai

Gender: male

Year Born: 1990

Chief Financial Officer
Summiti Jain

Gender: female

Year Born:

FAQs about Trinity League India Limited

Who is the CEO of the company?

The CEO is Devinder Kumar Jain.

What is the current market price of the stock?

The current price is ₹12.82.

What is the 52-week price range?

The range is ₹9.01-14.75.

What is the market capitalization of the company?

The market capitalization is ₹10.15 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -274.26.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Trinity League India Limited (ISIN: INE884X01011) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹10.15 crores and an average daily volume of 2,021 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.